Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists

(MedPage Today) — Loss of copayment assistance for drugs to treat neovascular age-related macular degeneration (nAMD) significantly disrupted patient care, including switching to less costly (and perhaps less effective) therapy, reliance on samples…